glp-1 in pregnancy JCI Insight The GLP-1 Pregnancy Paradox: The
Description
Mark Fendrick and Dariush Mozaffarian
As it is not fully approved, most of what we know about its safety and side effects emerges from ongoing and recent clinical trials
About CT-996 study 6 The CT-996-201 trial (NCT05814107) is a multi-part, multi-cohort Phase I randomised, double-blind, placebo-controlled, single- and multiple- ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of CT-996 in otherwise-healthy adults who are overweight or obese, with and without type 2 diabetes
The key during this phase is consistency
Glinpic'in yan etkileri var m
